ASCO 2022 Conference Coverage

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

ASCO 2022 Conference Coverage

Breast
Lung
GI
GU
Skin
GYN
Head & Neck
Leukemia
Lymphoma
Myeloma
MDS and MPN
Sarcoma

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

0:00

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

ASCO 2022 Immunotherapy Nuances in Locally Advanced NSCLC

By ASCO 2022 Conference Coverage FEATURING John Varlotto

32 views

July 6, 2022

Comments 0

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Lung

Lecture Summary - ASCO 2022 Five-Year Survival Outcomes From CheckMa…

ASCO 2022 Conference Coverage

L. Paz-Ares

100 views

ASCO 2022 Five-Year Survival Outcomes From CheckMate 227: Nivo + Ipi…

ASCO 2022 Conference Coverage

L. Paz-Ares

151 views

Lecture Summary - ASCO 2022 on the Phase 3 AcceleRET Lung Study: 1L …

ASCO 2022 Conference Coverage

F. de Marinis

27 views

ASCO 2022 on the Phase 3 AcceleRET Lung Study: 1L Pralsetinib in RET…

ASCO 2022 Conference Coverage

F. de Marinis

182 views

Lecture Summary - Pralsetinib in Patients (pts) With Advanced or Met…

ASCO 2022 Conference Coverage

L. Wirth

22 views

ASCO 2022 Updated Data From the ARROW Trial: Pralsetinib in Patients…

ASCO 2022 Conference Coverage

L. Wirth

158 views

Lecture Summary - ASCO 2022 3-Year Update From CheckMate 9LA: 1L Niv…

ASCO 2022 Conference Coverage

L. Paz-Ares

24 views

ASCO 2022 3-Year Update From CheckMate 9LA: 1L Nivo + Ipi + 2 Cycles…

ASCO 2022 Conference Coverage

L. Paz-Ares

479 views

ASCO 2022 Immunotherapy Nuances in Locally Advanced NSCLC

ASCO 2022 Conference Coverage

J. Varlotto

32 views

Lecture Summary - ASCO 2022 Immunotherapy Nuances in Locally Advance…

ASCO 2022 Conference Coverage

J. Varlotto

25 views

ASCO 2022 on Acquired EGFR-Resistant Mutations in NSCLC

ASCO 2022 Conference Coverage

L. Raez

275 views

Lecture Summary - ASCO 2022 on Acquired EGFR-Resistant Mutations in …

ASCO 2022 Conference Coverage

L. Raez

14 views

Lecture Summary - ASCO 2022 on Recurrent SCLC: Can We Change the Par…

ASCO 2022 Conference Coverage

R. Gentzler

17 views

Lecture Summary - ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo i…

ASCO 2022 Conference Coverage

B. Chul Cho

15 views

ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo in 1L mNSCLC: AE Ma…

ASCO 2022 Conference Coverage

B. Chul Cho

62 views

ASCO 2022 on IO and Chemo-IO for NSCLC With Novel Actionable Oncogen…

ASCO 2022 Conference Coverage

L. Mazzeo, M. Occhipinti

186 views

Lecture Summary - ASCO 2022 Impact of Trilaciclib on Multilineage Ch…

ASCO 2022 Conference Coverage

J. Goldschmidt

18 views

ASCO 2022 Impact of Trilaciclib on Multilineage Chemo-Induced Myelos…

ASCO 2022 Conference Coverage

J. Goldschmidt

93 views

ASCO 2022 Predictors of Biomarker Testing Among Pts With mNSCLC

ASCO 2022 Conference Coverage

N. Robert

692 views

ASCO 2022 on a Phase I, Open-Label, Dose Escalation, Confirmation, a…

ASCO 2022 Conference Coverage

J. Heymach

106 views

Lecture Summary - ASCO 2022 on a Phase I, Open-Label, Dose Escalatio…

ASCO 2022 Conference Coverage

J. Heymach

15 views

Taking on Goliath: Targeting KRAS in NSCLC

Jia Luo

1.2K views

ASCO 2022 on Phase 3 ATLANTIS Trial: Analysis of Patients With Relap…

ASCO 2022 Conference Coverage

A. Navarro

253 views

ASCO 2022 on Telisotuzumab Vedotin in Advanced c-Met Overexpressing …

ASCO 2022 Conference Coverage

R. Camidge

181 views

Lecture Summary - ASCO 2022 Analysis of Patients With Relapsed SCLC …

ASCO 2022 Conference Coverage

A. Navarro

24 views

Lecture Summary - ASCO 2022 on Telisotuzumab Vedotin in Advanced c-M…

ASCO 2022 Conference Coverage

R. Camidge

289 views

ASCO 2022 on TROPION-Lung08: Dato-DXd + Pembro in Treatment-Naïve Ad…

ASCO 2022 Conference Coverage

B. Levy

133 views

Lecture Summary - ASCO 2022 on ctDNA Shed as a Tool to Select Immune…

ASCO 2022 Conference Coverage

B. Besse

89 views

Lecture Summary - ASCO 2022 Combi-TED: A Multicenter Phase II Trial …

ASCO 2022 Conference Coverage

F. Cappuzzo

22 views

ASCO 2022 Combi-TED: A Multicenter Phase II Trial Evaluating Efficac…

ASCO 2022 Conference Coverage

F. Cappuzzo

65 views

Lecture Summary - ASCO 2022 on Stereotactic Radiosurgery vs. WBRT in…

ASCO 2022 Conference Coverage

K. Gaebe

47 views

ASCO 2022 on Stereotactic Radiosurgery vs. WBRT in SCLC and Intracra…

ASCO 2022 Conference Coverage

K. Gaebe

431 views

Lecture Summary - ASCO 2022 on KEYVIBE-008: Randomized, Phase 3 Stud…

ASCO 2022 Conference Coverage

J. Sands

43 views

ASCO 2022 on KEYVIBE-008: Randomized, Phase 3 Study of 1L Vibostolim…

ASCO 2022 Conference Coverage

J. Sands

510 views

Lecture Summary - ASCO 2022 on Clinical and Genomic Characteristics …

ASCO 2022 Conference Coverage

J. Sands

21 views

ASCO 2022 on Clinical and Genomic Characteristics of Pts With Durabl…

ASCO 2022 Conference Coverage

J. Sands

280 views

Lecture Summary - ASCO 2022 Three-Year Outcomes and Correlative Anal…

ASCO 2022 Conference Coverage

B. Ricciuti

114 views

ASCO 2022 Three-Year Outcomes and Correlative Analyses in Patients W…

ASCO 2022 Conference Coverage

B. Ricciuti

320 views

ASCO 2022 on GEOMETRY-N Trial: Neoadjuvant and Adjuvant Capmatinib i…

ASCO 2022 Conference Coverage

J. Lee

966 views